Wikisage, the free encyclopedia of the second generation, is digital heritage
Aspirin: Difference between revisions
Jump to navigation
Jump to search
m (→Links) |
m (→ATC) |
||
| Line 14: | Line 14: | ||
==ATC== | ==ATC== | ||
Salicylic acid and derivates | Salicylic acid and derivates | ||
* | *Acetylsalicylic acid (INN) | ||
[https://www.whocc.no/atc_ddd_index/?code=N02BA01 N02BA01] | [https://www.whocc.no/atc_ddd_index/?code=N02BA01 N02BA01] | ||
Revision as of 12:16, 24 January 2019
Aspirin is an AINE [1] A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibig platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin [2]
Kawasaki
Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory to this treatment [3]
Hutchinson Gliford Progeria
Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications [4]
ATC
Salicylic acid and derivates
- Acetylsalicylic acid (INN)
Links
- ↑ https://karmel.miraheze.org/wiki/PenaRC2/profilaxis_AAS
- ↑ https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]
- ↑ A case report of refractory kawasaki disease
- ↑ Hutchinson-Gilford Progeria Syndrome
